MedPath

effect of habb-o-shefa in treatment of adictio

Not Applicable
Conditions
addiction.
Mental and behavioural disorders due to use of opioids
Registration Number
IRCT2015101024446N1
Lead Sponsor
Vice Chancellor for research of Shahed University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

age 18 - 65 years old ; DSM-IV criteria for addiction ; healthy condition ; detoxification at least one month before intervention; signed informed consent
Exclusion criteria: Addiction to alcohol ; positive history of other psychological disorders ; taking psychiatric drug ; pregnancy and breast feeding ; serious medical disease such as glaucoma ,retention ,epilepsy ,parkinsonism ; allergic reaction to medical herbs ; incidence of side effect

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: Baseline, 4,8 and12 weeks after starting the medication. Method of measurement: Hamilton rating scale for anxiety.;Craving. Timepoint: Baseline, 4,8 and12 weeks after starting the medication. Method of measurement: Craving Beliefs Questionnaire.;Quality of life. Timepoint: Baseline, 4,8 and12 weeks after starting the medication. Method of measurement: wHO-QOL Brief.
Secondary Outcome Measures
NameTimeMethod
Side effect. Timepoint: 4,8 and12 weeks after starting the medication. Method of measurement: physical examination and checklist.
© Copyright 2025. All Rights Reserved by MedPath